Infliximab discontinuation in patients with ulcerative colitis
Lancet Gastroenterol Hepatol
.
2021 Jun;6(6):412-413.
doi: 10.1016/S2468-1253(21)00103-5.
Epub 2021 Apr 20.
Author
Bella Ungar
1
Affiliation
1
Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Ramat Gan affiliated to Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: bella.geyshis.ungar@gmail.com.
PMID:
33887263
DOI:
10.1016/S2468-1253(21)00103-5
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Monoclonal / adverse effects
Colectomy
Colitis, Ulcerative* / drug therapy
Colitis, Ulcerative* / surgery
Humans
Infliximab / adverse effects
Substances
Antibodies, Monoclonal
Infliximab